Involvement of the miR-128-3p/KDM3A/NLRP3 Axis in High Glucose-Induced Inflammatory Injury in Retinal Endothelial Cells
- PMID: 40999581
- DOI: 10.1002/kjm2.70120
Involvement of the miR-128-3p/KDM3A/NLRP3 Axis in High Glucose-Induced Inflammatory Injury in Retinal Endothelial Cells
Abstract
This study explores the regulatory mechanism of the miR-128-3p in diabetic retinopathy (DR)-associated inflammatory injury. A cellular model of DR was established by inducing immortalized human retinal endothelial cells (IM-HRECs) with high-glucose (HG). Cell viability was evaluated by CCK-8 assay, and the levels of TNF-α, IL-1β, and IL-10 were measured by ELISA. RT-qPCR was performed to determine miR-128-3p expression, and miR-128-3p mimics were transfected into cells to verify its regulatory role in DR-associated inflammatory injury. miR-128-3p was predicted by Starbase to bind to the 3' UTR of KDM3A, which was verified by dual-luciferase assay. The expressions of KDM3A and NLRP3 in cells were examined by Western blotting, and the enrichment of KDM3A and H3K9me2 on the NLRP3 promoter was measured by Ch-IP assay. The results revealed that HG treatment significantly reduced both IM-HREC viability and IL-10 levels, increased the levels of TNF-α and IL-1β, and downregulated the expression of miR-128-3p. Overexpression of miR-128-3p reduced inflammation in IM-HRECs induced by HG. The proposed mechanism involves targeting of the KDM3A 3' UTR by miR-128-3p, leading to reduced KDM3A expression, while KDM3A increased NLRP3 expression by reducing H3K9me2. In conclusion, upregulation of miR-128-3p increases the histone H3K9me2 level by inhibiting KDM3A expression, thereby reducing NLRP3 expression and suppressing DR inflammatory injury.
Keywords: H3K9me2; KDM3A; diabetic retinopathy; inflammatory injury; miR‐128‐3p.
© 2025 The Author(s). The Kaohsiung Journal of Medical Sciences published by John Wiley & Sons Australia, Ltd on behalf of Kaohsiung Medical University.
References
-
- W. Wang and A. C. Y. Lo, “Diabetic Retinopathy: Pathophysiology and Treatments,” International Journal of Molecular Sciences 19, no. 6 (2018): 1816.
-
- J. Tang and T. S. Kern, “Inflammation in Diabetic Retinopathy,” Progress in Retinal and Eye Research 30, no. 5 (2011): 343–358.
-
- F. Semeraro, A. Cancarini, R. dell'Omo, S. Rezzola, M. R. Romano, and C. Costagliola, “Diabetic Retinopathy: Vascular and Inflammatory Disease,” Journal Diabetes Research 2015 (2015): 582060.
-
- U. M. Kinuthia, A. Wolf, and T. Langmann, “Microglia and Inflammatory Responses in Diabetic Retinopathy,” Frontiers in Immunology 11 (2020): 564077.
-
- J. D. Boss, P. K. Singh, H. K. Pandya, et al., “Assessment of Neurotrophins and Inflammatory Mediators in Vitreous of Patients With Diabetic Retinopathy,” Investigative Ophthalmology & Visual Science 58, no. 12 (2017): 5594–5603.
Grants and funding
LinkOut - more resources
Full Text Sources